4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001628280-25-054059
Chief Scientific Officer sold 535 shares at $3.94 ($2,105)
- Chief Scientific Officer acquired 535 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-11-24 | Option exercise 10b5-1 | +535 | $0.06 | $32 | 535 | D |
| Moreadith Randall Chief Scientific Officer | 2025-11-24 | Sale 10b5-1 | −535 | $3.94 | $2,105 | 0 | D |
| Derivatives | |||||||
| Moreadith Randall Chief Scientific Officer | 2025-11-24 | Option exercise · Stock Option (right to buy) 10b5-1 | −535 | 384,151 | D | ||
| Open-market sales · 535 sh · avg $3.94 · $2,105 | |||||||
Loading xslF345X05/wk-form4_1764123603.xml…